Drug-eluting balloons in coronary artery disease - current and future perspectives

Interventional Cardiology: Reviews, Research, Resources

Volumn 6, Issue 2, 2011, Pages 157-160

  Belkacemi, Anouar ^a   Agostoni, Pierfrancesco ^a   Voskuil, Michiel ^a   Doevendans, Pieter ^a   Stella, Pieter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angioplasty; Complex coronary lesions; Drug eluting balloon; Drug eluting stent

Indexed keywords

IOPROMIDE; PACLITAXEL;

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTICLE; BALLOON; BARE METAL STENT; BLOOD VESSEL WALL; CATHETER; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DRUG ELUTING BALLOON; DRUG ELUTING STENT; DRUG SOLUBILITY; HUMAN; HYDROPHILICITY; LIPOPHILICITY; NEOINTIMA; NONHUMAN; ZOTAROLIMUS ELUTING CORONARY STENT;

EID: 85017340761     PISSN: 17561477     EISSN: 17561485     Source Type: Journal    
DOI: 10.15420/icr.2011.6.2.157     Document Type: Article

References (30)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group, N Engl J Med, 1994;331:489-95
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 2003;349:1315-23
3. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents, J Am Coll Cardiol, 2005;45:2088-92
4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study, Lancet, 2007;369:667-8
5. Jarvie JL, Foody JM, Predictors of early discontinuation of dual-antiplatelet therapy: room for improvement, Circulation, 122:946-8
6. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA, Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry, Catheter Cardiovasc Interv, 2008;71:629-35
7. Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping, Thromb Haemost, 2009;101:201-6
8. Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxelcoated balloon catheter, Clin Res Cardiol, 2008;97:773-81
9. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter, N Engl J Med, 2006;355:2113-24
10. Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis, Circulation, 2004;110:810-4
11. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter, Clin Res Cardiol, 99:165-74
12. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis, Circulation, 2009;119:2986-94
13. Rowinsky EK, Donehower RC, Paclitaxel (taxol), N Engl J Med, 1995;332:1004-14
14. Posa A, Hemetsberger R, Petnehazy O, et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries, Coron Artery Dis, 2008;19:243-7
15. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing, Arterioscler Thromb Vasc Biol, 2007;27:1500-10
16. Mori T, Kinoshita Y, Watanabe A, et al. Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro, Cancer Chemother Pharmacol, 2006;58:665-72
17. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery, Circulation, 1997;96:636-45
18. Scheller B, Speck U, Schmitt A, et al. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation, J Am Coll Cardiol, 2003;42:1415-20
19. Posa A, Nyolczas N, Hemetsberger R, et al. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries, Catheter Cardiovasc Interv, 2010;76:395-403
20. Scheller B, Speck U, Romeike B, et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model, Eur Heart J, 2003;24:1462-7
21. Habara S, Mitsudo K, Kadota K, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis, JACC Cardiovasc Interv, 2011;4:149-54
22. Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study, Heart, 96:1291-6
23. Cremers B, Biedermann M, Mahnkopf D, et al. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model, Clin Res Cardiol, 2009;98:325-30
24. Belkacemi A, Agostoni P, Stella PR, Drug-eluting balloons and bifurcations, a new future for treatment?, EuroIntervention Supplement, 2011;7(Suppl. K)K66-9
25. Cremers B, Toner J, Schwartz LB, et al. Inhibition of coronary neointimal hyperplasia in swine using a novel zotarolimuseluting balloon catheter, Eur Heart J, 2009;30(Abstract Suppl.):532
26. Buerke M, Guckenbiehl M, Schwertz H, et al. Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury, Biochim Biophys Acta, 2007;1774:5-15
27. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl J Med, 2008;358:689-99
28. Birkmeier KA, Kastrati A, Byrne RA, et al. Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients, Catheter Cardiovasc Interv, 2011;77:494-501
29. Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel-and sirolimus-eluting stents in small coronary vessels, Eur Heart J, 2006;27:260-6
30. Stella PR, Belkacemi A, Agostoni P, Drug-eluting balloons and Bifurcations, a new future for treatment?, EuroIntervention Supplement, 2010;6(Suppl. J)J161-4